Stroke in the ED

Author: Katherine Henderson / Editor: Jonathon Birns / Reviewer: Thomas MacMahon, Nadarajah Prasanna / Code: / Published: 20/08/2021

Before commencing this session you should complete the Learning session:

After completing this session you will be able to:

  • Outline the epidemiology and pathophysiology of stroke
  • Explain the link between the physical presentation of stroke patients and the vascular territory affected
  • List examples of relevant assessment and scoring tools for stroke
  • Describe the appropriate investigation of acute stroke
  • List the therapeutic options in the treatment of acute stroke
  • Explain the balance of risk and benefit of thrombolytic therapy for stroke
START MODULE

References:

  1. Royal College of Physicians, National clinical guideline for stroke. Prepared by the Intercollegiate Stroke Working Party. 2016, Royal College of Physicians: London.
  2. Department of Health, National Stroke Strategy. 2007, Department of Health: London.
  3. Harbison, J., et al., Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the face arm speech test. Stroke, 2003. 34(1): p. 71-6.
  4. Robinson TG, Reid A, Haunton VJ, et al., The face arm speech test: does it encourage rapid recognition of important stroke warning symptoms? Emerg Med J. 2013 Jun;30(6):467-71.
  5. Wolters, F.J., et al., Sustained impact of UK FAST-test public education on response to stroke: a population-based time-series study. Int J Stroke, 2015. 10(7): p. 1108-14.
  6. Dombrowski, S.U., et al., The stroke ‘Act FAST’ campaign: remembered but not understood? Int J Stroke, 2015. 10(3): p. 324-30.
  7. Nor, A.M., et al., The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument. Lancet Neurol, 2005. 4(11): p. 727-34.
  8. Hand, P.J., et al., Distinguishing between stroke and mimic at the bedside: the brain attack study. Stroke, 2006. 37(3): p. 769-75.
  9. National Institute for Health and Care Excellence (NICE). NICE Pathways. Acute Stroke. 2016.
  10. Hacking, C. and J. Jones. Hyperdense MCA sign. [cited 2016 31 December]; Available from: https://radiopaedia.org/articles/hyperdense-mca-sign.
  11. Hacke, W., et al., Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med, 2008. 359(13): p. 1317-29.
  12. Tyson, S.F. and P. Nightingale, The effects of position on oxygen saturation in acute stroke: a systematic review. Clin Rehabil, 2004. 18(8): p. 863-71.
  13. Olavarria, V.V., et al., Head position and cerebral blood flow velocity in acute ischemic stroke: a systematic review and meta-analysis. Cerebrovasc Dis, 2014. 37(6): p. 401-8.
  14. O’Driscoll, B.R., L.S. Howard, and A.G. Davison, BTS guideline for emergency oxygen use in adult patients. Thorax, 2008. 63 Suppl 6: p. vi1-68.
  15. Alonso de Lecinana, M., et al., Guidelines for the treatment of acute ischaemic stroke. Neurologia, 2014. 29(2): p. 102-22.
  16. National Institute for Health and Care Excellence (NICE), Stroke and transient ischaemic attack in over 16s: diagnosis and initial management. Clinical guideline [CG68]. 2008: London.
  17. Hajat, C., S. Hajat, and P. Sharma, Effects of poststroke pyrexia on stroke outcome : a meta-analysis of studies in patients. Stroke, 2000. 31(2): p. 410-4.
  18. Brott, T., et al., Measurements of acute cerebral infarction: a clinical examination scale. Stroke, 1989. 20(7): p. 864-70.
  19. Jauch, E.C., et al., Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 2013. 44(3): p. 870-947.
  20. Wardlaw, J.M., et al., Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev, 2014(7): p. CD000213.
  21. Royal College of Physicians Care Quality Improvement Department (CQID) on behalf of the Intercollegiate Stroke Working Party, Sentinel Stroke National Audit Programme (SSNAP). Acute organisational audit report. National Report England, Wales and Northern Ireland. November 2016. 2016, Royal College of Physicians: London.
  22. Royal College of Physicians on behalf of the Intercollegiate Stroke Working Party, Sentinel Stroke National Audit Programme (SSNAP) Summary Report for April – July 2016 admissions and discharges. 2016, Royal College of Physicians: London.
  23. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, Tissue plasminogen activator for acute ischemic stroke. N Engl J Med, 1995. 333(24): p. 1581-7.
  24. Hacke, W., et al., Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA, 1995. 274(13): p. 1017-25.
  25. Hacke, W., et al., Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet, 1998. 352(9136): p. 1245-51.
  26. I. S. T. collaborative group, et al., The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet, 2012. 379(9834): p. 2352-63.
  27. Royal College of Emergency Medicine. Acute Ischaemic Stroke and Intravenous Thrombolysis. A position statement. 3rd December 2015. 2015 [cited 2017 01 January].
  28. Brown, M.D., et al., Clinical Policy: Use of Intravenous Tissue Plasminogen Activator for the Management of Acute Ischemic Stroke in the Emergency Department. Ann Emerg Med, 2015. 66(3): p. 322-333 e31.
  29. Newman, D. Thrombolytics for Acute Ischemic Stroke. 2013 [cited 2017 1 January].
  30. Emberson, J., et al., Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet, 2014. 384(9958): p. 1929-35.
  31. Committee for Proprietary Medicinal Products (CPMP), Summary information on a referral opinion following an arbitration pursuant to article 29 of directive 2001/83/EC, for Actilyse. 2002, European Agency for the Evaluation of Medicinal Products (EMEA),: London.
  32. Chen, Z.-M. and CAST (Chinese Acute Stroke Trial) Collaborative Group, CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet, 1997. 349(9066): p. 1641-9.
  33. International Stroke Trial (IST) Collaborative Group, The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet, 1997. 349(9065): p. 1569-81.
  34. Geeganage, C.M., et al., Dual or Mono Antiplatelet Therapy for Patients With Acute Ischemic Stroke or Transient Ischemic Attack: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Stroke, 2012. 43(4): p. 1058-1066.
  35. Sandercock, P.A., C. Counsell, and E.J. Kane, Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev, 2015(3): p. CD000024.
  36. Rodrigues, F.B., et al., Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis. BMJ, 2016. 353: p. i1754.
  37. Chen, C.J., et al., Endovascular vs medical management of acute ischemic stroke. Neurology, 2015. 85(22): p. 1980-90.
  38. National Institute for Health and Care Excellence (NICE), Mechanical clot retrieval for treating acute ischaemic stroke. Interventional procedures guidance [IPG548]. 2016, NICE: London.
  39. Stroke Unit Trialists’ Collaboration, Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev, 2013(9): p. CD000197.
  40. Juttler, E., et al., Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke. N Engl J Med, 2014. 370(12): p. 1091-100.
  41. Lu, X., et al., Decompressive craniectomy for the treatment of malignant infarction of the middle cerebral artery. Sci Rep, 2014. 4: p. 7070.
  42. Ropper , A.H., Hemicraniectomy To Halve or Halve Not. New England Journal of Medicine, 2014. 370(12): p. 1159-1160.
  43. Chowdhury, M.M., et al., Antithrombotic Treatment for Acute Extracranial Carotid Artery Dissections: A Meta-Analysis. European Journal of Vascular and Endovascular Surgery, 2015. 50(2): p. 148-156.
  44. Schievink , W.I., Spontaneous Dissection of the Carotid and Vertebral Arteries. New England Journal of Medicine, 2001. 344(12): p. 898-906.
  45. Lyrer, P. and S. Engelter, Antithrombotic drugs for carotid artery dissection. Cochrane Database Syst Rev, 2010(10): p. CD000255.
  46. Markus, H.S., et al., Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial. Lancet Neurol, 2015. 14(4): p. 361-7.

Module Content

Expand All

Leave a Reply

BACK TO POST